These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 17199177)

  • 1. [Usefulness of the antisense and triplex anti-IGF-1 techniques for postoperative cellular gene therapy of malignant gliomas expressing IGF-1].
    Kasprzak HA; Trojan J; Bierwagen M; Kopiński P; Jarocki P; Bartczak K; Czapiewska J
    Neurol Neurochir Pol; 2006; 40(6):509-15; discussion 516. PubMed ID: 17199177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF-I triple helix gene therapy of rat and human gliomas.
    Trojan LA; Kopinski P; Mazurek A; Chyczewski L; Ly A; Jarocki P; Nikliński J; Shevelev A; Trzos R; Pan Y; Gitis DJ; Bierwagen M; Czapiewska JL; Wei MX; Michalkiewicz J; Henin D; Popiela T; Evrard F; Kasprzak H; Anthony D; Trojan J
    Rocz Akad Med Bialymst; 2003; 48():18-27. PubMed ID: 14737936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma.
    Ly A; Duc HT; Kalamarides M; Trojan LA; Pan Y; Shevelev A; François JC; Noël T; Kane A; Henin D; Anthony DD; Trojan J
    Mol Pathol; 2001 Aug; 54(4):230-9. PubMed ID: 11477137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial.
    Westphal M; Ylä-Herttuala S; Martin J; Warnke P; Menei P; Eckland D; Kinley J; Kay R; Ram Z;
    Lancet Oncol; 2013 Aug; 14(9):823-33. PubMed ID: 23850491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment modalities for malignant gliomas with reference to their pathophysiology].
    Kobayashi S; Takakura K
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):11-7. PubMed ID: 3942392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Survival of newly diagnosed malignant glioma patients on combined modality therapy].
    Yang QY; Shen D; Sai K; Jiang XB; Ke C; Zhang XH; Mou YG; Chen ZP
    Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(1):8-10. PubMed ID: 23578444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination treatment of malignant brain tumors. Results of initial experiences].
    Bauer B; Adrian G
    Psychiatr Neurol Med Psychol (Leipz); 1983 Sep; 35(9):566-73. PubMed ID: 6316389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic factors in malignant gliomas].
    Ushio Y; Kochi M
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):643-8. PubMed ID: 8678527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
    Juratli TA; Schackert G; Krex D
    Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic guided laser-induced interstitial thermotherapy (SLITT) in gliomas with intraoperative morphologic monitoring in an open MR: clinical expierence.
    Leonardi MA; Lumenta CB
    Minim Invasive Neurosurg; 2002 Dec; 45(4):201-7. PubMed ID: 12494354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgical treatment combined with radiotherapy and chemotherapy in an unselected population of patients with malignant glioma].
    Viñolas N; Arbaiza D; Graus F; Caral L; Ribalta T; Mercader JM; Daniels M; Biete A; Ferrer E; Tolosa E
    Med Clin (Barc); 1993 Nov; 101(17):641-3. PubMed ID: 8289507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas.
    Lima-Ramos V; Pacheco-Figueiredo L; Costa S; Pardal F; Silva A; Amorim J; Lopes JM; Reis RM
    Cancer Genet Cytogenet; 2008 Jan; 180(1):14-9. PubMed ID: 18068527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
    Mizoe JE; Tsujii H; Hasegawa A; Yanagi T; Takagi R; Kamada T; Tsuji H; Takakura K;
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):390-6. PubMed ID: 17459607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in high-grade malignant glioma. A multivariate analysis of 76 cases with postoperative radiotherapy.
    Würschmidt F; Bünemann H; Heilmann HP
    Strahlenther Onkol; 1995 Jun; 171(6):315-21. PubMed ID: 7597616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
    Gnekow AK; Kortmann RD; Pietsch T; Emser A
    Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Accelerated hyperfractionation in the treatment of malignant glioma].
    Sugawara T; Nakazawa M; Mizutani Y; Hyodoh H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Mar; 54(4):278-85. PubMed ID: 8177703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor type I biology and targeting in malignant gliomas.
    Trojan J; Cloix JF; Ardourel MY; Chatel M; Anthony DD
    Neuroscience; 2007 Mar; 145(3):795-811. PubMed ID: 17320297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of the method of treatment on mean survival time of patients with glial brain tumors].
    Koziak M; Kuran W; Lipczyńska-Lojkowska W; Wisławski J
    Neurol Neurochir Pol; 1986; 20(3):207-13. PubMed ID: 3785551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malignant brain glioma--a catamnestic study of 100 operated patients].
    Victor S; Lausberg G
    Zentralbl Neurochir; 1991; 52(2):59-68. PubMed ID: 1659065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged survival of rats with intracranial C6 gliomas by treatment with TGF-beta antisense gene.
    Liau LM; Fakhrai H; Black KL
    Neurol Res; 1998 Dec; 20(8):742-7. PubMed ID: 9864741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.